Home › Liposarcoma › Pennsylvania
Liposarcoma clinical trials in Pennsylvania
4 studies for Liposarcoma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Nov 12, 2026 · NCT06541262Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
- Saint Vincent Hospital, Erie
- Jefferson Hospital, Jefferson Hills
- Forbes Hospital, Monroeville
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06422806Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05711615Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Saint Vincent Hospital, Erie
- Jefferson Hospital, Jefferson Hills
- Forbes Hospital, Monroeville
- and 9 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT04031677From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.